Eagle Pharmaceuticals
EGRX
#10862
Rank
A$4.73 M
Marketcap
A$0.36
Share price
0.00%
Change (1 day)
-92.13%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: A$4.73 Million

As of July 2026 Eagle Pharmaceuticals has a market cap of A$4.73 Million. This makes Eagle Pharmaceuticals the world's 10862th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$4.73 M-45.58%
2025A$8.7 M-24.02%
2024A$11.45 M-88.51%
2023A$99.69 M-82.17%
2022A$0.55 B-38.36%
2021A$0.90 B14.93%
2020A$0.78 B-32.53%
2019A$1.16 B46.98%
2018A$0.79 B-22.06%
2017A$1.02 B-40.06%
2016A$1.70 B-10.5%
2015A$1.90 B615.91%
2014A$0.26 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$911.98 B 19,249,509.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$439.44 B 9,275,300.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$1.559 T 32,908,569.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$290.84 B 6,138,788.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$170.97 B 3,608,644.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$154.78 B 3,267,076.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$58.09 B 1,226,138.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel